3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Stomach Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Hand-Foot Syndrome
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Bile Duct Neoplasms
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Carboplatin
8
Paclitaxel
7
Gemcitabine
7
Irinotecan
6
Radiotherapy
4
Oxaliplatin
4
Capecitabine
4
Leucovorin
3
Fluorouracil
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cisplatin
3
Bevacizumab
3
etoposide phosphate
2
Trastuzumab
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Etoposide
2
Amifostine
2
Albumin-Bound Paclitaxel
2
tipifarnib
1
tegafur-gimeracil-oteracil
1
sintilimab
1
pertuzumab
1
pemigatinib
1
pembrolizumab
1
olaparib
1
ivosidenib
1
ipatasertib
1
erythromycin propionate-N-acetylcysteinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms, Unknown Primary
×
tegafur-gimeracil-oteracil
×
Clear all
NCT01845337
2023-05-12
TOFFEE
University of Edinburgh
Phase 2
Completed
59 enrolled